Spironolactone for all hypertensive patients?

被引：1
|
作者：
Rosendorff, Clive [1 ,2 ]
机构：
[1] James J Peters VA Med Ctr, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Dept Med, New York, NY USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷 / 01期
关键词：
SELECTIVE ALDOSTERONE BLOCKER; BLOOD-PRESSURE; EPLERENONE;
D O I：
10.1097/HJH.0b013e328334262f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] EFFECT OF SPIRONOLACTONE IN HYPERTENSIVE PATIENTS
    CRANE, MG
    HARRIS, JJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1970, 260 (06): : 311 - +
  • [2] SPIRONOLACTONE IN HYPERTENSIVE PATIENTS - OLIGEMIC AND ANTIHYPERTENSIVE EFFECTS
    GEORGOPOULOS, AJ
    PAGE, IH
    DUSTAN, H
    ARCHIVES OF INTERNAL MEDICINE, 1961, 108 (03) : 389 - &
  • [3] Effect of spironolactone on impaired fibrinolysis of hypertensive patients
    Yalcin, AU
    Dincer, M
    Aslan, V
    Gulbas, Z
    KIDNEY & BLOOD PRESSURE RESEARCH, 2002, 25 (04): : 260 - 264
  • [4] SPIRONOLACTONE AND AMILORIDE IN HYPERTENSIVE PATIENTS WITH AND WITHOUT ALDOSTERONE EXCESS
    HOEFNAGELS, WHL
    DRAYER, JIM
    SMALS, AGH
    KLOPPENBORG, PWC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) : 317 - 323
  • [5] THE PHARMACOLOGY OF A COMBINED SPIRONOLACTONE AND PROPRANOLOL TABLET IN HYPERTENSIVE PATIENTS
    LEWIS, LD
    BENNETT, PN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (05) : P536 - P536
  • [6] EFFICACY OF VERAPAMIL HYDROCHLOROTHIAZIDE SPIRONOLACTONE THERAPY IN HYPERTENSIVE BLACK PATIENTS
    HUGHES, GS
    COWART, TD
    CONRADI, EC
    CLINICAL PHARMACY, 1987, 6 (04): : 322 - 326
  • [7] AMILORIDE, SPIRONOLACTONE, AND KCL IN THIAZIDE-TREATED HYPERTENSIVE PATIENTS
    RAMSAY, LE
    HETTIARACHCHI, J
    FRASER, R
    MORTON, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 533 - 543
  • [8] Should All Patients with Resistant Hypertension Receive Spironolactone?
    Rosa, Jan
    Zelinka, Tomas
    Petrak, Ondrej
    Strauch, Branislav
    Holaj, Robert
    Widimsky, Jiri, Jr.
    CURRENT HYPERTENSION REPORTS, 2016, 18 (11)
  • [9] Should All Patients with Resistant Hypertension Receive Spironolactone?
    Ján Rosa
    Tomáš Zelinka
    Ondřej Petrák
    Branislav Štrauch
    Robert Holaj
    Jiří Widimský
    Current Hypertension Reports, 2016, 18
  • [10] Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?
    Teo, Koon K.
    JOURNAL OF HYPERTENSION, 2017, 35 (01) : 36 - 38
12345